Clinical Trial Update: Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study assessing the safety and pharmacokinetics of YH22162 in healthy volunteers for hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• YH22162

Snippet

Sponsor: Yuhan Corporation | Conditions: Hypertension | Phase 1 | Status: COMPLETED